Prevalence of Anal Sphincter Defects After Childbirth (PRADA)

December 1, 2023 updated by: Jose-M Ramirez, Universidad de Zaragoza

Prevalence of Anal Sphincter Defects After Childbirth in Primiparous Women

The incidence of obstetric sphincter tears has risen to 15-30% and the prevalence of anal incontinence (AI) symptoms after childbirth may be as high as 40%. The present study aims to evaluate the prevalence of anal sphincter defects after childbirth in primiparous women-

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

The incidence of sphincter defect in women has raised in recently with current rates as high as 30% after vaginal deliveries. Fecal incontinence could be present at the time of the delivery but it is a real problem longtime after, in women older than 60 years.

It is of great importance not only an early detection but to indicates the best possible management as soon as posible.

The design is a prospective observational study including primiparous woman, without previous anal surgery.

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Zaragoza, Spain, 50009
        • Hospital Clinico Lozano Blesa

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Primaparous pregnat

Description

Inclusion Criteria:

  • Primiparous pregnant patients aged >18 y, evaluated during pregnancy and after childbirth, including both vaginal and cesarean deliveries.

Exclusion Criteria:

  • Non primiparous patients and patients with a history of anal surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
EAUS
Patients with EAUS pre and postpartum
Endoanal Ultrasound pre- and postpartum

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Integrity of anal sphincter
Time Frame: 4 months
No defect detected on EAUS
4 months
Defects on anal canal
Time Frame: 4 months
Disruption of any of the anal canal sphincters
4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
QoL
Time Frame: 4 months
According to a dedicated questionnaire
4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jose-M Ramirez, Prof, Universidad de Zaragoza

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2024

Primary Completion (Estimated)

January 1, 2025

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

December 29, 2021

First Submitted That Met QC Criteria

January 13, 2022

First Posted (Actual)

January 19, 2022

Study Record Updates

Last Update Posted (Estimated)

December 4, 2023

Last Update Submitted That Met QC Criteria

December 1, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fecal Incontinence

Clinical Trials on Endoanal Ultrasound (EAUS)

3
Subscribe